InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Jonjones325 post# 147985

Tuesday, 04/17/2018 8:00:24 PM

Tuesday, April 17, 2018 8:00:24 PM

Post# of 464406
“Genomic signature found and to be reported at an upcoming conference. The signature allows them to accurately predict who will benefit most from 2-73. This way the data can be used in all future trials.”

This is quite a dramatic statement - do we interpret this statement that patients with these signature will benefit from A2-73 such that it will have positive impact on Alz?

If they PR it officially - it will be big news and lot of questions as to veracity of this claim
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News